Ambler, PA, United States of America

Idriss Bennacef



Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Idriss Bennacef in Alzheimer's Imaging

Introduction

Idriss Bennacef, an inventive mind based in Ambler, Pennsylvania, has made significant contributions to the field of medical imaging. With two patents to his name, Bennacef's work focuses primarily on developing imaging agents that can enhance the diagnosis and treatment of neurodegenerative diseases, particularly Alzheimer's disease.

Latest Patents

Bennacef's latest patents revolve around novel pyrrolo[2,3-C]pyridine compounds that serve as imaging agents for neurofibrillary tangles associated with Alzheimer’s disease. The innovative compounds are described as suitable for imaging various aggregates such as tau aggregates, beta-amyloid aggregates, and alpha-synuclein aggregates. These inventions involve methods for utilizing the compounds as tracers in positron emission tomography (PET) imaging, enabling the in vivo study of tau deposits in the brain. Such techniques not only facilitate the diagnosis of Alzheimer’s but also provide a means to measure the clinical efficacy of therapeutic agents targeting tau pathology.

Career Highlights

Currently, Idriss Bennacef is associated with Merck Sharp & Dohme Corporation, where he continues to engage in pioneering research. His expertise and dedication to innovation in medical imaging technology are notable, as they play a crucial role in advancing Alzheimer's disease research and treatment.

Collaborations

Throughout his career, Bennacef has collaborated with esteemed colleagues, including Eric Hostetler and Thomas J Greshock. Their combined efforts contribute to the multi-disciplinary approach needed in the realm of pharmaceutical innovations and neuroimaging.

Conclusion

In summary, Idriss Bennacef stands out as a leading inventor in the field of neuroimaging, specifically targeting Alzheimer's disease. His patents highlight the potential for improved diagnosis and treatment of neurodegenerative diseases through innovative imaging agents, marking a significant step forward for both the medical community and patients affected by such conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…